Removal of prior authorization for medication-assisted treatment: Impact on opioid use and policy implications in a Medicare Advantage population

BACKGROUND: More than 30% of Medicare beneficiaries and 40% of patients dually eligible for Medicare and Medicaid use opioids. With an estimated 8%-12% of patients developing an opioid use disorder (OUD) after initiating opioids, opioid misuse is a significant public health challenge, especially amo...

Full description

Bibliographic Details
Main Authors:	Bizzell, B. (Author), Ferries, E. (Author), Racsa, P. (Author), Rhodes, C. (Author), Suehs, B. (Author)
Format:	Article
Language:	English
Published:	Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:	adult Adult aged Aged Aged, 80 and over Analgesics, Opioid anticonvulsive agent antidepressant agent Article behavior disorder benzodiazepine derivative buprenorphine plus naloxone clinical evaluation clinical outcome cohort analysis controlled study Cross-Sectional Studies cross-sectional study drug dependence treatment drug misuse drug use emergency ward female Female glucocorticoid health care policy health care utilization health service hospital admission hospital patient human Humans incidence low drug dose major clinical study male Male medicare Medicare Part C medication assisted treatment mental disease middle aged Middle Aged morphine muscle relaxant agent naltrexone narcotic analgesic agent nonsteroid antiinflammatory agent opiate opiate addiction organizational policy Organizational Policy population prescription prescription drug prior authorization Prior Authorization recurrence risk Retrospective Studies retrospective study treatment outcome United States very elderly young adult Young Adult
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Removal of prior authorization for medication-assisted treatment: Impact on opioid use and policy implications in a Medicare Advantage population

Internet

Similar Items